Monocyte response to LPS after exposure to corticosteroids and chloroquine with implications for systemic lupus erythematosus.
Cepika
A-M
AM
Department of Pediatrics, Children's Hospital Zagreb, Klaićeva 16, Zagreb, Croatia. acepika@gmail.com
Bendelja
K
K
Vergles
J M
JM
Malenica
B
B
Kapitanovic
S
S
Gagro
A
A
D000305:Adrenal Cortex Hormones / Q000494:pharmacology* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000494:pharmacology / Q000627:therapeutic use; D002478:Cells, Cultured; D002738:Chloroquine / Q000494:pharmacology* / Q000627:therapeutic use; D003907:Dexamethasone / Q000494:pharmacology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism; D009000:Monocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic / Q000235:genetics; D051197:Toll-Like Receptor 4 / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000378:metabolism
D000305:Adrenal Cortex Hormones; D018501:Antirheumatic Agents; D015850:Interleukin-6; D008070:Lipopolysaccharides; D016328:NF-kappa B; C495345:TLR4 protein, human; D051197:Toll-Like Receptor 4; D014409:Tumor Necrosis Factor-alpha; D003907:Dexamethasone; D002738:Chloroquine